From the Editor-in-Chief
Research is leading to treatments that target cancer’s support system.
by William G. Nelson, MD, PhD
Sexual Health in Adolescent and Young Adult Survivors | First CAR-T Cell Therapy Approved for Multiple Myeloma | Going Flat | The Impact of HPV Vaccination | What’s Next?
Your Cancer Guide
Cancer survivors can build routines to address their needs during and after treatment.
by Hester Hill Schnipper
Caregiving With Confidence
A little bit of planning can help streamline cancer care, even when you are caregiving from afar.
by Karen J. Bannan
Cancer screenings and clinical trials have been seriously disrupted by the pandemic.
by Nicholas Warren, PhD
Tumor testing can help determine whether certain cancers are likely to respond to immunotherapy drugs.
by Kendall K. Morgan
Cancer researcher Vicky Forster draws from her own experience with childhood leukemia to emphasize patient voices in cancer research.
by Bradley Jones
The rapid development of mRNA COVID-19 vaccines could spark advances in similar treatments for cancer.
by Stephen Ornes
Health care providers and communities are making strides toward ensuring equity in cancer treatment.
by Marci A. Landsmann
Low-Budget Eats | Fighting Fit
When Liza Marshall was diagnosed with stage III breast cancer, she and her husband, oncologist John Marshall, had to chart new waters.
Ensuring that doctors respect your cultural background, addressing anxiety caused by the pandemic, and discussing end-of-life plans.
Students Lara Jabbour and Nazanin Nayeri work to cheer up hospital staff and patients.
Facts and Stats
A knowledge of the different types of skin cancer can help you remain vigilant.
After adapting remote patient monitoring programs to cancer patients with COVID-19, cancer centers delve deeper into the programs’ value for cancer patients undergoing treatment.
by Jon Kelvey
The FDA recently expressed a new commitment to testing cancer drugs at lower doses, rather than defaulting to the highest dose most people can tolerate.
by Marcus A. Banks
Can discussion of health inequities lead to actionable change?
Cancer survivor Laurie Adami reflects on her experience participating in a clinical trial that ultimately contributed to the March 2021 approval of a CAR-T cell therapy for follicular lymphoma.
by Laurie Adami
AACR Dialogues showcase honest discussion about delivering equitable care.
AACR's blog writers provide coverage of the AACR Annual Meeting 2021.
While melanoma is less common than skin cancers like basal cell carcinoma or squamous cell carcinoma, it is much more deadly.
Learning Medicare’s ABCDs
donate to the AACR